Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 76
Keywords: Neuroendocrine tumors
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Silje Udjus Johansen, Rasmus Goll, Anna Nordborg, Kai Vernstad, Einar Paul Helge Jensen, Jon Ragnar Florholmen, Terkel Hansen
Journal:
Neuroendocrinology
Neuroendocrinology (2024)
Published Online: 23 December 2024
...-chain fatty acids (SCFAs), important metabolites derived from the gut microbiota, are described to carry both protective and promoting features in cancer development. Limited research exists on neuroendocrine tumors (NETs) and their association with microbiota-derived SCFAs. The aim of this study...
Journal Articles
Uliana A. Tsoy, Polina S. Sokolnikova, Ekaterina N. Kravchuk, Pavel A. Ryazanov, Alexandra A. Kozyreva, Yulia V. Fomicheva, Liana S. Aramisova, Tatiana L. Karonova, Anna A. Kostareva, Elena Grineva
Journal:
Neuroendocrinology
Neuroendocrinology 1–21.
Published Online: 13 November 2024
...Uliana A. Tsoy; Polina S. Sokolnikova; Ekaterina N. Kravchuk; Pavel A. Ryazanov; Alexandra A. Kozyreva; Yulia V. Fomicheva; Liana S. Aramisova; Tatiana L. Karonova; Anna A. Kostareva; Elena Grineva Introduction: Neuroendocrine tumors (NETs) frequently have a genetic basis, and the range of genes...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2024) 114 (11): 981–992.
Published Online: 09 September 2024
...ZheXu Cao; JiangSheng Huang; Xia Long Introduction: Neuroendocrine tumors (NETs) are a heterogeneous group of epithelial tumors originating from different anatomical sites, and identifying the gut microbiota and metabolic mechanisms involved in the onset of NETs may help to develop appropriate...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2024) 114 (8): 775–785.
Published Online: 05 June 2024
... from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 18F-fluorodeoxyglucose positron emission tomography/computed tomography 68Ga-somatostatin receptor analog positron emission tomography/computed tomography Neuroendocrine tumors Bone...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2024) 114 (2): 111–119.
Published Online: 13 September 2023
... cohort with other studies [ 10, 15 ] were included for the analysis of some preoperative variables that were not dealt with in the other studies. [email protected] 1 03 2023 5 09 2023 13 09 2023 Lymph node metastasis Neuroendocrine tumors Pancreas Meta-analysis...
Journal Articles
Nitya Raj, Kelley Coffman, Tiffany Le, Richard Kinh Gian Do, Johnathan Rafailov, Ye Choi, Joanne F. Chou, Marinela Capanu, Mark Dunphy, Josef J. Fox, Ravinder K. Grewal, Ryan P. Reddy, Christopher Riedl, Heiko Schoder, Lisa Bodei, Diane Reidy-Lagunes
Journal:
Neuroendocrinology
Neuroendocrinology (2022) 112 (12): 1177–1186.
Published Online: 24 May 2022
... received FDA approval in 2018 to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (NETs). Little data are available on response and outcomes for well-differentiated (WD) high-grade (HG) NETs treated with 177 Lu-DOTATATE. Materials and Methods: Patients with WD HG NETs...
Journal Articles
Salvatore Paiella, Luca Landoni, Sarah Tebaldi, Michele Zuffante, Matteo Salgarello, Sara Cingarlini, Mirko D’Onofrio, Alice Parisi, Giacomo Deiro, Erminia Manfrin, Beatrice Bianchi, Greta Montagnini, Stefano Francesco Crinò, Claudio Bassi, Roberto Salvia
Journal:
Neuroendocrinology
Neuroendocrinology (2022) 112 (2): 143–152.
Published Online: 15 February 2022
... gallium ( 68 Ga)-DOTA-peptides and 18 fluorine-fluoro-2-deoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) scans in the workup of pancreatic neuroendocrine tumors (PanNETs) is controversial. This study aimed at assessing both tracers’ capability to identify tumors...
Journal Articles
Maroin Kalifi, Thomas Walter, Laurent Milot, Valérie Hervieu, Ingrid Millot, Benjamin Gibert, Colette Roche, Julien Forestier, Catherine Lombard-Bohas, Arnaud Pasquer, Gilles Poncet
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (8): 786–793.
Published Online: 24 August 2021
...Maroin Kalifi; Thomas Walter; Laurent Milot; Valérie Hervieu; Ingrid Millot; Benjamin Gibert; Colette Roche; Julien Forestier; Catherine Lombard-Bohas; Arnaud Pasquer; Gilles Poncet Introduction: Small-intestinal neuroendocrine tumors (SI-NET) are situated preferentially within the ileum. The aim...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (11): 1086–1098.
Published Online: 19 March 2021
...Lauren M. Raymond; Tetiana Korzun; Adel Kardosh; Kenneth J. Kolbeck; Rodney Pommier; Erik S. Mittra Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are the most common form of neuroendocrine neoplasia, but there is no current consensus for the sequencing of approved therapies, particularly...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2022) 112 (1): 34–42.
Published Online: 12 January 2021
...Jane E. Rogers; Michael Lam; Daniel M. Halperin; Cecile G. Dagohoy; James C. Yao; Arvind Dasari We evaluated outcomes of treatment with 5-fluorouracil (5-FU), doxorubicin, and streptozocin (FAS) in well-differentiated pancreatic neuroendocrine tumors (PanNETs) and its impact on subsequent therapy...
Journal Articles
Alberto Bongiovanni, Chiara Liverani, Flavia Foca, Valentina Fausti, Giandomenico Di Menna, Laura Mercatali, Alessandro De Vita, Nada Riva, Sebastiano Calpona, Giacomo Miserocchi, Chiara Spadazzi, Claudia Cocchi, Toni Ibrahim
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (9): 895–906.
Published Online: 20 November 2020
... and 83.7% TEM) with a median age of 59 years (range 26–85) years. ECOG performance status was 0–2. Carcinoid syndrome was reported in 12 (12.6%) patients. Twenty (21.1%) patients with grade (G) 3 neuroendocrine carcinoma (NEC) and 9 (9.4%) with G3 neuroendocrine tumors (NETs) were included in the analysis...
Journal Articles
Maxime Barat, Philippe Soyer, Fatima Al Sharhan, Benoit Terris, Ammar Oudjit, Sébastien Gaujoux, Romain Coriat, Christine Hoeffel, Anthony Dohan
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (11): 1099–1110.
Published Online: 13 November 2020
...Maxime Barat; Philippe Soyer; Fatima Al Sharhan; Benoit Terris; Ammar Oudjit; Sébastien Gaujoux; Romain Coriat; Christine Hoeffel; Anthony Dohan Objectives: The aim of the study was to discriminate hepatic metastases from pancreatic neuroendocrine tumors (pNET) and hepatic metastases from midgut...
Journal Articles
Clarisse Dromain, Anders Sundin, Pavan Najran, Hector Vidal Trueba, Marco Dioguardi Burgio, Joakim Crona, Marta Opalinska, Luciana Carvalho, Regis Franca, Philip Borg, Naik Vietti Violi, Niklaus Schaefer, Carlos Lopez, Daniela Pezzutti, Louis de Mestier, Angela Lamarca, Frederico Costa, Marianne Pavel, Maxime Ronot
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (9): 831–839.
Published Online: 27 July 2020
... Pavel; Maxime Ronot Introduction: Tumor growth rate (TGR), percentage of change in tumor volume/month, has been previously identified as an early radiological biomarker for treatment monitoring in neuroendocrine tumor (NET) patients. We assessed the performance and reproducibility of TGR at 3 months...
Journal Articles
Francesca Terracciano, Alessia Capone, Andrea Montori, Maria Rinzivillo, Stefano Partelli, Francesco Panzuto, Emanuela Pilozzi, Paolo Giorgio Arcidiacono, Claudio Sette, Gabriele Capurso
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (8): 739–751.
Published Online: 02 July 2020
... during treatments is coupled with a change in the proliferative ability of cells [ 9 ]. Nevertheless, the specific molecular changes involved in acquisition and maintenance of resistance to everolimus remain largely unknown. Neuroendocrine tumors Everolimus Acquired drug resistance MYC Cyclin...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (6): 580–585.
Published Online: 02 July 2020
...Taymeyah Al-Toubah; Mauro Cives; Tiffany Valone; Kirsten Blue; Jonathan Strosberg Background: Secretory tumor markers traditionally measured in patients with neuroendocrine tumors (NET) are lacking sensitivity and specificity, and consequently they are of limited clinical utility. The NETest...
Journal Articles
Leonidas Nikolaos Diamantopoulos, Faidon-Marios Laskaratos, Markos Kalligeros, Ruchir Shah, Shaunak Navalkissoor, Gopinath Gnanasegaran, Jamie Banks, Jack Smith, Benjamin Jacobs, Michail Galanopoulos, Dalvinder Mandair, Martyn Caplin, Christos Toumpanakis
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (7): 650–659.
Published Online: 15 June 2020
... of somatostatin analogs (SSAs) are increasingly utilized in the management of inoperable/metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs), progressing on standard 4-weekly regimens. Objective: To evaluate the antiproliferative effect of 3-weekly SSA administration in a retrospective GEP-NET...
Journal Articles
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (5): 490–504.
Published Online: 11 May 2020
...Mark Kidd; Alexandra Kitz; Ignat Drozdov; Irvin Modlin Background: The NETest is a multigene assay comprising 51 circulating neuroendocrine tumor (NET)-specific transcripts. The quotient of the 51-gene assay is based upon an ensemble of machine learning algorithms. Eight cancer hallmarks or “omes...
Journal Articles
Yanji Luo, Xin Chen, Jie Chen, Chenyu Song, Jingxian Shen, Huanhui Xiao, Minhu Chen, Zi-Ping Li, Bingsheng Huang, Shi-Ting Feng
Journal:
Neuroendocrinology
Neuroendocrinology (2020) 110 (5): 338–350.
Published Online: 29 April 2020
... linear unit layer; Pooling, 3D max pooling layer; GlobalPooling, 3D global average pooling layer. Pancreatic neoplasms Neuroendocrine tumors Deep learning Tomography, spiral computed Neoplasm grading Pancreatic neuroendocrine neoplasms (pNENs) are the second most common pancreatic...
Journal Articles
Servane Gay-Chevallier, Louis de Mestier, Julie Perinel, Julien Forestier, Valérie Hervieu, Philippe Ruszniewski, Ingrid Millot, Pierre-Jean Valette, Mathieu Pioche, Catherine Lombard-Bohas, Fabien Subtil, Mustapha Adham, Thomas Walter
Journal:
Neuroendocrinology
Neuroendocrinology (2021) 111 (8): 718–727.
Published Online: 24 April 2020
..., local, regional lymph node, or distant metastatic disease) were collected. Duodenal neoplasms Neuroendocrine tumors Management Endoscopy Surgery Duodenal neuroendocrine neoplasms (dNEN) account for 3.5–5.6% of gastroenteropancreatic NEN [ 1, 2 ] and up to 3% of duodenal neoplasms [ 3...
Journal Articles
Louis de Mestier, Anne-Laure Védie, Matthieu Faron, Jérôme Cros, Vinciane Rebours, Olivia Hentic, Christine Do Cao, Pascal Bardet, Philippe Lévy, Alain Sauvanet, Philippe Ruszniewski, Pascal Hammel
Journal:
Neuroendocrinology
Neuroendocrinology (2020) 110 (11-12): 967–976.
Published Online: 03 December 2019
... diabetes mellitus (DM) and the recurrence of pancreatic neuroendocrine tumors (PanNET) following curative intent surgery. Methods: We included patients who underwent surgical resection of nonmetastatic well-differentiated PanNET. Exacerbation of DM was defined as the postoperative occurrence of DM...
1